Form 4 Filing for Zhai Yifan

This filing details transactions made by Zhai Yifan, Chief Medical Officer of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG), on May 20th and 21st, 2026. The transactions primarily involve restricted stock units (RSUs) and options. Zhai Yifan acquired various RSUs and options, with some vesting on May 21st, 2026. Additionally, there were dispositions of RSUs. Some transactions were direct, while others were indirect and involved shares held by the reporting person's spouse or entities controlled by the reporting person, as detailed in the footnotes. The filing also includes a Power of Attorney document authorizing attorneys-in-fact to handle SEC filings on behalf of Yifan Zhai.